Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/LA-JOLLA-PHARMACEUTICAL-C-23894309/news/La-Jolla-Pharmaceutical-Doses-First-Patient-in-Phase-1-Clinical-Trial-of-LJPC-401-in-Patients-at-R-21247227/?utm_source=whatsapp&utm_medium=social&utm_campaign=share